Freddy Jimenez
General Counsel bei CELLDEX THERAPEUTICS, INC.
Vermögen: 1 Mio $ am 31.03.2024
Profil
Freddy A.
Jimenez is currently the Director & General Counsel at The Food & Drug Law Institute and the Senior Vice President & General Counsel at Celldex Therapeutics, Inc. He previously worked as the Head-Pharmaceutical Regulatory Legal Group at Johnson & Johnson, an Associate-Food & Drug Practice at Akin, Gump, Strauss, Hauer & Feld LLP, and as a Liaison at R.W.
Johnson Pharmaceutical Research Institute.
Mr. Jimenez obtained his undergraduate degree from Brandeis University and his graduate degree from Rutgers School of Law (Camden).
Bekannte Unternehmensbeteiligungen
Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
---|---|---|---|---|
13.02.2024 | 25 924 ( 0,04% ) | 1 Mio $ | 31.03.2024 |
Aktive Positionen von Freddy Jimenez
Unternehmen | Position | Beginn |
---|---|---|
CELLDEX THERAPEUTICS, INC. | General Counsel | 01.02.2016 |
The Food & Drug Law Institute
The Food & Drug Law Institute Miscellaneous Commercial ServicesCommercial Services The Food & Drug Law Institute is a nonprofit membership organization that provides education, training, publications, and professional engagement opportunities in the field of food and drug law. The non-profit company is based in Washington. The American company offers a platform for stakeholders to inform innovative public policy, law, and regulation. Christine M. Simmon has been the CEO of the company since 2022. | Director/Board Member | - |
Ehemalige bekannte Positionen von Freddy Jimenez
Unternehmen | Position | Ende |
---|---|---|
Akin, Gump, Strauss, Hauer & Feld LLP
Akin, Gump, Strauss, Hauer & Feld LLP Miscellaneous Commercial ServicesCommercial Services Akin Gump Strauss Hauer & Feld LLP provides legal services. The firm's areas of practice includes appellate, litigation, business and commercial litigation, dispute resolution, government contracts, internal investigations, labor and employment, oil and gas patent, trademark and copyright infringement, product liability and toxic tort securities litigation. The company was founded in 1971 and is headquartered in Washington, DC. | Corporate Officer/Principal | 01.01.1999 |
R.W. Johnson Pharmaceutical Research Institute | Corporate Officer/Principal | 01.01.1997 |
JOHNSON & JOHNSON | General Counsel | - |
Ausbildung von Freddy Jimenez
Brandeis University | Undergraduate Degree |
Rutgers School of Law (Camden) | Graduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Börsennotierte Unternehmen | 2 |
---|---|
JOHNSON & JOHNSON | Health Technology |
CELLDEX THERAPEUTICS, INC. | Health Services |
Private Unternehmen | 3 |
---|---|
Akin, Gump, Strauss, Hauer & Feld LLP
Akin, Gump, Strauss, Hauer & Feld LLP Miscellaneous Commercial ServicesCommercial Services Akin Gump Strauss Hauer & Feld LLP provides legal services. The firm's areas of practice includes appellate, litigation, business and commercial litigation, dispute resolution, government contracts, internal investigations, labor and employment, oil and gas patent, trademark and copyright infringement, product liability and toxic tort securities litigation. The company was founded in 1971 and is headquartered in Washington, DC. | Commercial Services |
The Food & Drug Law Institute
The Food & Drug Law Institute Miscellaneous Commercial ServicesCommercial Services The Food & Drug Law Institute is a nonprofit membership organization that provides education, training, publications, and professional engagement opportunities in the field of food and drug law. The non-profit company is based in Washington. The American company offers a platform for stakeholders to inform innovative public policy, law, and regulation. Christine M. Simmon has been the CEO of the company since 2022. | Commercial Services |
R.W. Johnson Pharmaceutical Research Institute |